In a new study presented at MAD-ID, omadacycline was found to have an 86% clinical success rate across a wide-range of infections and pathogens in an immunocompromised population.
Sean Van Helden, PharmD
Advertisement
Van Helden is a Postdoctoral Infectious Diseases Pharmacotherapy fellow at Wayne State University.
Articles by Sean Van Helden, PharmD
There is value in leveraging the contributions of nurses, laboratorians, and informaticists in antimicrobial stewardship.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
One Third of Chronic Hepatitis B Patients Are Lost to Follow-Up
2
Higher Acceptability of 1 Injectable in First Head-to-Head Comparison of Long-Acting PrEP
3
Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients
4
Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?
5
